{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T12:43:25Z","timestamp":1775133805254,"version":"3.50.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T00:00:00Z","timestamp":1667520000000},"content-version":"vor","delay-in-days":1648,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003100","name":"F\u00e9d\u00e9ration Fran\u00e7aise de Cardiologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003100","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004431","name":"Fondation de France","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["DEQ20170336737"],"award-info":[{"award-number":["DEQ20170336737"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1111\/jth.14003","type":"journal-article","created":{"date-parts":[[2018,3,15]],"date-time":"2018-03-15T11:54:24Z","timestamp":1521114864000},"page":"933-945","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Acute coronary syndrome remodels the antiplatelet aggregation properties of HDL particle subclasses"],"prefix":"10.1016","volume":"16","author":[{"given":"C.","family":"Garcia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Mont\u00e9e","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Faccini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Series","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Meilhac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.\u2010V.","family":"Cantero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Le Faouder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Elbaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Payrastre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Vindis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/jth.14003_bb0010","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0002-9149(99)00489-0","article-title":"Evidence that high\u2010density lipoprotein cholesterol is an independent predictor of acute platelet\u2010dependent thrombus formation","volume":"84","author":"Naqvi","year":"1999","journal-title":"Am J Cardiol"},{"key":"10.1111\/jth.14003_bb0015","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/01.ATV.18.6.861","article-title":"HDL3\u2010mediated inhibition of thrombin\u2010induced platelet aggregation and fibrinogen binding occurs via decreased production of phosphoinositide\u2010derived second messengers 1,2\u2010diacylglycerol and inositol 1,4,5\u2010tris\u2010phosphate","volume":"18","author":"Nofer","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.14003_bb0020","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1161\/CIRCULATIONAHA.109.870709","article-title":"Reconstituted high\u2010density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol efflux","volume":"120","author":"Calkin","year":"2009","journal-title":"Circulation"},{"key":"10.1111\/jth.14003_bb0025","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14003_bb0030","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1111\/jth.14003_bb0035","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/CIRCGENETICS.114.000663","article-title":"Pharmacogenomic determinants of the cardiovascular effects of dalcetrapib","volume":"8","author":"Tardif","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1111\/jth.14003_bb0040","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/j.1582-4934.2009.00713.x","article-title":"Small, dense HDL 3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A\u2010I","volume":"14","author":"de Souza","year":"2010","journal-title":"J Cell Mol Med"},{"key":"10.1111\/jth.14003_bb0045","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1161\/01.ATV.0000091338.93223.E8","article-title":"Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress","volume":"23","author":"Kontush","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.14003_bb0050","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/MOL.0b013e32833bcdc1","article-title":"Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities","volume":"21","author":"Kontush","year":"2010","journal-title":"Curr Opin Lipidol"},{"key":"10.1111\/jth.14003_bb0055","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1194\/jlr.R036095","article-title":"Unraveling the complexities of the HDL lipidome","volume":"54","author":"Kontush","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1111\/jth.14003_bb0060","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000346463","article-title":"High\u2010density lipoprotein subfractions \u2013 what the clinicians need to know","volume":"124","author":"Pirillo","year":"2013","journal-title":"Cardiology"},{"key":"10.1111\/jth.14003_bb0065","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1160\/th13-09-0775","article-title":"High\u2010density lipoprotein from patients with coronary heart disease loses anti\u2010thrombotic effects on endothelial cells: impact on arterial thrombus formation","volume":"112","author":"Holy","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14003_bb0070","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/clinchem\/39.6.960","article-title":"Sequential ultracentrifugation micromethod for separation of serum lipoproteins and assays of lipids, apolipoproteins, and lipoprotein particles","volume":"39","author":"Brousseau","year":"1993","journal-title":"Clin Chem"},{"key":"10.1111\/jth.14003_bb0075","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0022-2275(20)38777-0","article-title":"Sequential microultracentrifugation of lipoproteins in 100 microliters of serum","volume":"27","author":"Kupke","year":"1986","journal-title":"J Lipid Res"},{"key":"10.1111\/jth.14003_bb0080","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1182\/blood-2009-02-205328","article-title":"The new tyrosine\u2010kinase inhibitor and anticancer drug dasatinib reversibly affects platelet activation in vitro and in vivo","volume":"114","author":"Gratacap","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.14003_bb0085","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jchromb.2013.06.014","article-title":"LC\u2010MS\/MS method for rapid and concomitant quantification of pro\u2010inflammatory and pro\u2010resolving polyunsaturated fatty acid metabolites","volume":"932","author":"Le Faouder","year":"2013","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1111\/jth.14003_bb0090","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1365-2141.2007.06973.x","article-title":"Common risk factors for both arterial and venous thrombosis","volume":"140","author":"Lowe","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1111\/jth.14003_bb0095","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1096\/fj.12-225169","article-title":"Inhibitory effects of in vivo oxidized high\u2010density lipoproteins on platelet aggregation: evidence from patients with abetalipoproteinemia","volume":"27","author":"Calzada","year":"2013","journal-title":"FASEB J"},{"key":"10.1111\/jth.14003_bb0100","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1038\/ncomms5257","article-title":"Identification of platelet function defects by multi\u2010parameter assessment of thrombus formation","volume":"5","author":"de Witt","year":"2014","journal-title":"Nat Commun"},{"key":"10.1111\/jth.14003_bb0105","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/01.ATV.0000067429.46333.7B","article-title":"Expression of human scavenger receptor B1 on and in human platelets","volume":"23","author":"Imachi","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.14003_bb0110","doi-asserted-by":"crossref","first-page":"15422","DOI":"10.1073\/pnas.222421399","article-title":"Discovery of chemical inhibitors of the selective transfer of lipids mediated by the HDL receptor SR\u2010BI","volume":"99","author":"Nieland","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.14003_bb0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1432-1033.1994.00021.x","article-title":"Phosphorylation of focal adhesion vasodilator\u2010stimulated phosphoprotein at Ser157 in intact human platelets correlates with fibrinogen receptor inhibition","volume":"225","author":"Horstrup","year":"1994","journal-title":"Eur J Biochem"},{"key":"10.1111\/jth.14003_bb0120","doi-asserted-by":"crossref","first-page":"10316","DOI":"10.1073\/pnas.89.21.10316","article-title":"High density lipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors","volume":"89","author":"Bowry","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1111\/jth.14003_bb0125","first-page":"239","article-title":"Antiplatelet effects of conjugated linoleic acid isomers","volume":"1438","author":"Truitt","year":"1999","journal-title":"Biochem Biophys Acta"},{"key":"10.1111\/jth.14003_bb0130","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1182\/blood-2014-09-599530","article-title":"High\u2010density lipoprotein modulates thrombosis by preventing von Willebrand factor self\u2010association and subsequent platelet adhesion","volume":"127","author":"Chung","year":"2016","journal-title":"Blood"},{"key":"10.1111\/jth.14003_bb0135","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1055\/s-0038-1649788","article-title":"von Willebrand factor, soluble P\u2010selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis","volume":"74","author":"Blann","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.14003_bb0140","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.atherosclerosis.2010.12.026","article-title":"Native high\u2010density lipoproteins inhibit platelet activation via scavenger receptor BI: role of negatively charged phospholipids","volume":"215","author":"Brodde","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1111\/jth.14003_bb0145","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0022-2275(20)31693-X","article-title":"Apolipoprotein A\u2010I conformation markedly influences HDL interaction with scavenger receptor BI","volume":"42","author":"de Beer","year":"2001","journal-title":"J Lipid Res"},{"key":"10.1111\/jth.14003_bb0150","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cvr\/cvu137","article-title":"High\u2010density lipoprotein as a modulator of platelet and coagulation responses","volume":"103","author":"van der Stoep","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1111\/jth.14003_bb0155","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/S0022-2275(20)34910-5","article-title":"Identification and characterization of LRP8 (apoER2) in human blood platelets","volume":"40","author":"Riddell","year":"1999","journal-title":"J Lipid Res"},{"key":"10.1111\/jth.14003_bb0160","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0005-2736(03)00022-1","article-title":"Lipid rafts are critical membrane domains in blood platelet activation processes","volume":"1610","author":"Bodin","year":"2003","journal-title":"Biochem Biophys Acta"},{"key":"10.1111\/jth.14003_bb0165","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jbior.2013.09.006","article-title":"Class I PI 3\u2010kinases signaling in platelet activation and thrombosis: PDK1\/Akt\/GSK3 axis and impact of PTEN and SHIP1","volume":"54","author":"Laurent","year":"2014","journal-title":"Adv Biol Regul"},{"key":"10.1111\/jth.14003_bb0170","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1111\/j.1538-7836.2008.03169.x","article-title":"Mitogen\u2010activated protein kinases in hemostasis and thrombosis","volume":"6","author":"Adam","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.14003_bb0175","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1182\/blood-2007-08-107813","article-title":"Oxidized high\u2010density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI","volume":"111","author":"Valiyaveettil","year":"2008","journal-title":"Blood"},{"key":"10.1111\/jth.14003_bb0180","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1042\/BJ20050796","article-title":"Vasodilator\u2010stimulated phosphoprotein (VASP) is phosphorylated on Ser157 by protein kinase C\u2010dependent and \u2010independent mechanisms in thrombin\u2010stimulated human platelets","volume":"393","author":"Wentworth","year":"2006","journal-title":"Biochem J"},{"key":"10.1111\/jth.14003_bb0185","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.numecd.2013.12.011","article-title":"HDL lipid composition is profoundly altered in patients with type 2 diabetes and atherosclerotic vascular disease","volume":"24","author":"Morgantini","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1111\/jth.14003_bb0190","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/j.febslet.2008.02.001","article-title":"Oxidation by hypochlorite converts protective HDL into a potent platelet agonist","volume":"582","author":"Assinger","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1111\/jth.14003_bb0195","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/ATVBAHA.109.186031","article-title":"Proteomic analysis of defined HDL subpopulations reveals particle\u2010specific protein clusters: relevance to antioxidative function","volume":"29","author":"Davidson","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.14003_bb0200","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.abb.2009.05.005","article-title":"Distinct HDL subclasses present similar intrinsic susceptibility to oxidation by HOCl","volume":"487","author":"Chantepie","year":"2009","journal-title":"Arch Biochem Biophys"},{"key":"10.1111\/jth.14003_bb0205","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1182\/blood.V63.4.848.848","article-title":"Inhibition of platelet function by cis\u2010unsaturated fatty acids","volume":"63","author":"MacIntyre","year":"1984","journal-title":"Blood"},{"key":"10.1111\/jth.14003_bb0210","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1210\/jc.2014-4214","article-title":"Glycoxidized HDL, HDL enriched with oxidized phospholipids and HDL from diabetic patients inhibit platelet function","volume":"100","author":"Le","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1111\/jth.14003_bb0215","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/978-1-4615-9442-0_23","article-title":"Role of lipoxygenase products in platelet function: relation to fatty acid modified phospholipids","volume":"192","author":"Lagarde","year":"1985","journal-title":"Adv Exp Med Biol"},{"key":"10.1111\/jth.14003_bb0220","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1084\/jem.20132011","article-title":"18\u2010HEPE, an n\u20103 fatty acid metabolite released by macrophages, prevents pressure overload\u2010induced maladaptive cardiac remodeling","volume":"211","author":"Endo","year":"2014","journal-title":"J Exp Med"},{"key":"10.1111\/jth.14003_bb0225","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/ATVBAHA.108.178681","article-title":"HDL remodeling during the acute phase response","volume":"29","author":"Jahangiri","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.14003_bb0230","first-page":"1254","article-title":"Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A","volume":"1851","author":"Rached","year":"2015","journal-title":"Biochem Biophys Acta"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.14003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14003","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/jth.14003","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622010868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622010868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/jth.14003","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:20:30Z","timestamp":1761535230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622010868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1538783622010868"],"URL":"https:\/\/doi.org\/10.1111\/jth.14003","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute coronary syndrome remodels the antiplatelet aggregation properties of HDL particle subclasses","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.14003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2018 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}